← Eichor
Study identifier: NCT02821260 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Clinical Evaluation of the Efficacity of Epilepsy Surgery in Infants and Children

Condition: Epilepsy  ·  Sponsor: Fondation Ophtalmologique Adolphe de Rothschild

PhaseN/A
Planned participants500
Who can joinAll sexes, N/A to 18 Years
Healthy volunteersNo

About this study

The Pediatric Neurosurgery Service of the Rothschild Foundation (Paris) is the French leader center for surgery of epilepsy in infants and children. Postoperative follow-up of these children is performed during medical and neurosurgical consultations in order to assess the frequency of attacks and to reduce medication. On average, two postoperative consultations are carried out between 3 and 5 months and between 12 and 18 months. Beyond 18 months, some children may benefit from long-term monitoring at this center, but most children are followed by their neurologist . Therefore, the center has no rigorous and systematic collection of standardized data on the outcome of these patients. The purpose of this study is to evaluate the efficacy of the epilepsy surgery in children with a monitoring of 3 years.

This description comes directly from the study's public registry record.

Talk to the study team

Christine BULTEAU, MD  ·  cbulteau@fo-rothschild.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Fondation Ophtalmologique Adolphe de RothschildParis, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02821260